GERVASONI, SILVIA
GERVASONI, SILVIA
Dipartimento di Scienze Farmaceutiche
Human carnosinases: A brief history, medicinal relevance, and in silico analyses
2024 K. Chmielewska, S. Vittorio, S. Gervasoni, K. Dzierzbicka, I. Inkielewicz-Stepniak, G. Vistoli
Target Prediction by Multiple Virtual Screenings: Analyzing the SARS-CoV-2 Phenotypic Screening by the Docking Simulations Submitted to the MEDIATE Initiative
2024 S. Gervasoni, C. Manelfi, S. Adobati, C. Talarico, A.D. Biswas, A. Pedretti, G. Vistoli, A.R. Beccari
Antitumor activity of novel POLA1-HDAC11 dual inhibitors
2022 S. Dallavalle, L. Musso, R. Cincinelli, N. Darwiche, S. Gervasoni, G. Vistoli, M.B. Guglielmi, I. La Porta, M. Pizzulo, E. Modica, F. Prosperi, G. Signorino, F. Colelli, F. Cardile, A. Fucci, E.L. D'Andrea, A. Riccio, C. Pisano
Cyclo(His-Pro) Exerts Protective Carbonyl Quenching Effects through Its Open Histidine Containing Dipeptides
2022 L. Regazzoni, L. Fumagalli, A. Artasensi, S. Gervasoni, E. Gilardoni, A. Mazzolari, G. Aldini, G. Vistoli
Extensive Sampling of Molecular Dynamics Simulations to Identify Reliable Protein Structures for Optimized Virtual Screening Studies: The Case of the hTRPM8 Channel
2022 S. Gervasoni, C. Talarico, C. Manelfi, A. Pedretti, G. Vistoli, A.R. Beccari
Anosmin-1-Like Effect of UMODL1/Olfactorin on the Chemomigration of Mouse GnRH Neurons and Zebrafish Olfactory Axons Development
2022 E. Di Schiavi, G. Vistoli, R.M. Moretti, I. Corrado, G. Zuccarini, S. Gervasoni, L. Casati, D. Bottai, G.R. Merlo, R. Maggi
Discovery of a potent and highly selective Dipeptidyl Peptidase IV and Carbonic Anhydrase inhibitor as “antidiabesity” agent based on repurposing and morphing of WB-4101
2022 A. Artasensi, A. Angeli, C. Lammi, C. Bollati, S. Gervasoni, G. Baron, R. Matucci, C. Supuran, G. Vistoli, L. Fumagalli
COMPUTATIONAL APPROACHES TO STUDY METALLOPROTEINS AND ZINC-CONTAINING SYSTEMS
2021 S. Gervasoni
A multiscale approach to predict the binding mode of metallo beta-lactamase inhibitors
2021 S. Gervasoni, J. Spencer, P. Hinchliffe, A. Pedretti, F. Vairoletti, G. Mahler, A.J. Mulholland
Combining Different Docking Engines and Consensus Strategies to Design and Validate Optimized Virtual Screening Protocols for the SARS-CoV-2 3CL Protease
2021 C. Manelfi, J. Gossen, S. Gervasoni, C. Talarico, S. Albani, B. Joseph Philipp, F. Musiani, G. Vistoli, G. Rossetti, A. Rosario Beccari, A. Pedretti
Scaffold Hybridization Strategy Leads to the Discovery of Dopamine D3Receptor-Selective or Multitarget Bitopic Ligands Potentially Useful for Central Nervous System Disorders
2021 A. Bonifazi, A.H. Newman, T.M. Keck, S. Gervasoni, G. Vistoli, F. Del Bello, G. Giorgioni, P. Pavletic, W. Quaglia, A. Piergentili
The VEGA suite of programs: a versatile platform for cheminformatics and drug design projects
2021 A. Pedretti, A. Mazzolari, S. Gervasoni, L. Fumagalli, G. Vistoli
Tree2c: A flexible tool for enabling model deployment with special focus on cheminformatics applications
2020 A. Pedretti, A. Mazzolari, S. Gervasoni, G. Vistoli
Novel adamantyl retinoid-related molecules with POLA1 inhibitory activity
2020 R. Cincinelli, L. Musso, M.B. Guglielmi, I. La Porta, A. Fucci, E. Luca D'Andrea, F. Cardile, F. Colelli, G. Signorino, N. Darwiche, S. Gervasoni, G. Vistoli, C. Pisano, S. Dallavalle
A comprehensive mapping of the druggable cavities within the SARS-CoV-2 therapeutically relevant proteins by combining pocket and docking searches as implemented in pockets 2.0
2020 S. Gervasoni, G. Vistoli, C. Talarico, C. Manelfi, A.R. Beccari, G. Studer, G. Tauriello, A.M. Waterhouse, T. Schwede, A. Pedretti
Repositioning dequalinium as potent muscarinic allosteric ligand by combining virtual screening campaigns and experimental binding assays
2020 A. Mazzolari, S. Gervasoni, A. Pedretti, L. Fumagalli, R. Matucci, G. Vistoli
Combining molecular dynamics and docking simulations to develop targeted protocols for performing optimized virtual screening campaigns on the HTRPM8 channel
2020 C. Talarico, S. Gervasoni, C. Manelfi, A. Pedretti, G. Vistoli, A.R. Beccari
Development of a direct LC-ESI-MS method for the measurement of human serum carnosinase activity
2020 E. Gilardoni, S. Gervasoni, M. Maspero, C. Dallanoce, G. Vistoli, M. Carini, G. Aldini, L. Regazzoni
Novel Sustainable-by-Design HDAC Inhibitors for the Treatment of Alzheimer's Disease
2019 L.A.S. Romeiro, J.L. Da Costa Nunes, C. De Oliveira Miranda, G. Simoies Heyn Roth Cardoso, A.S. De Oliveira, A. Gandini, T. Kobrlova, O. Soukup, M. Rossi, J. Senger, M. Jung, S. Gervasoni, G. Vistoli, S. Petralla, F. Massenzio, B. Monti, M.L. Bolognesi
Rescoring and Linearly Combining: a Highly Effective Consensus Strategy for Virtual Screening Campaigns
2019 A. Pedretti, A. Mazzolari, S. Gervasoni, G. Vistoli